A Mediation Moderation Model between Self-Evaluative Emotions and Relapse Rate among Polysubstance Users: A Comparative Cross-Sectional Study
- PMID: 36833854
- PMCID: PMC9959136
- DOI: 10.3390/ijerph20043164
A Mediation Moderation Model between Self-Evaluative Emotions and Relapse Rate among Polysubstance Users: A Comparative Cross-Sectional Study
Abstract
A substantial portion of drug abuse research has concentrated on people with a single-substance-use disorder (SSUD), but many people abuse more than one drug. Studies have yet to examine how those with polysubstance-use disorder (PSUD) differ from those with an SSUD on the risk of relapse, self-evaluative emotions (e.g., shame and guilt), and personality factors (e.g., self-efficacy). Eleven rehab facilities in Lahore city, Pakistan were randomly chosen to provide a sample of 402 males with PSUD. For comparison, 410 age-matched males with SSUD were enlisted using a demographic form with eight questions, the State Shame and Guilt Scale, and the General Self-Efficacy Scale. Mediated moderation analysis was performed using Hayes' process macro. The results demonstrate that shame-proneness is positively associated with relapse rate. Guilt-proneness mediates the relationship between shame-proneness and relapse rate. Self-efficacy buffers the influence of shame-proneness on relapse rate. Although the mediation and moderation effects were found in both study groups, these effects were significantly stronger among people with PSUD than those with SSUD. To be more specific, people with PSUD reported a higher overall score on shame, guilt, and relapse rate. Additionally, people with SSUD indicated a higher score on self-efficacy than those with PSUD. The findings of this study suggest that drug rehab facilities should implement a variety of strategies to raise drug users' levels of self-efficacy, which will help to reduce their risk of relapse.
Keywords: comparative study; guilt-proneness; polysubstance users; relapse rate; self-efficacy; shame-proneness; single-substance users.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
Similar articles
-
Differential Associations between Guilt and Shame Proneness and Religious Coping Styles in a Diverse Sample of Young Adults.J Interpers Violence. 2023 Jan;38(1-2):NP670-NP697. doi: 10.1177/08862605221081931. Epub 2022 Mar 24. J Interpers Violence. 2023. PMID: 35324358
-
Proneness to guilt, shame, and pride in children with Autism Spectrum Disorders and neurotypical children.Autism Res. 2018 Jun;11(6):883-892. doi: 10.1002/aur.1937. Epub 2018 Feb 13. Autism Res. 2018. PMID: 29437299
-
Prone to feel guilty: Self-evaluative emotions in alcohol-dependence.Drug Alcohol Depend. 2017 Oct 1;179:78-82. doi: 10.1016/j.drugalcdep.2017.06.030. Epub 2017 Jul 24. Drug Alcohol Depend. 2017. PMID: 28756103
-
A Comparison of the Social-Adaptive Perspective and Functionalist Perspective on Guilt and Shame.Behav Sci (Basel). 2017 Dec 11;7(4):83. doi: 10.3390/bs7040083. Behav Sci (Basel). 2017. PMID: 29232888 Free PMC article. Review.
-
Small or big in the eyes of the other: on the developmental psychopathology of self-conscious emotions as shame, guilt, and pride.Clin Child Fam Psychol Rev. 2014 Mar;17(1):19-40. doi: 10.1007/s10567-013-0137-z. Clin Child Fam Psychol Rev. 2014. PMID: 23712881 Review.
Cited by
-
Labeled as "drug-seeking": nurses use harm reduction philosophy to reflect on mending mutual distrust between healthcare workers and people who use drugs.Front Public Health. 2023 Oct 16;11:1277562. doi: 10.3389/fpubh.2023.1277562. eCollection 2023. Front Public Health. 2023. PMID: 37908688 Free PMC article.
References
-
- Sawer F., Davis P., Gleeson K. Is shame a barrier to sobriety? A narrative analysis of those in recovery. Drugs Educ. Prev. Policy. 2020;27:79–85. doi: 10.1080/09687637.2019.1572071. - DOI
-
- De Guzman K.R., Snoswell C.L., Maier L.J., Winstock A.R., Ferris J.A., Puljevic C. Associations between mental illness and non-medical use of prescription opioids among a sample of people who use drugs in Australia and New Zealand. Drugs: Educ. Prev. Policy. 2022 doi: 10.1080/09687637.2022.2028726. - DOI
-
- Striley C.W., Hoeflich C.C., Viegas A.T., A Berkowitz L., Matthews E.G., Akin L.P., Iheanyi-Okeahialam C., Mansoor U., McCurdy C.R. Health Effects Associated With Kratom (Mitragyna speciosa) and Polysubstance Use: A Narrative Review. Subst. Abus. Res. Treat. 2022;16:11782218221095873. doi: 10.1177/11782218221095873. - DOI - PMC - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources